CDKN2A and histiocytic sarcoma: We also observed that the incidence of histiocytic sarcoma was significantly higher in hTS/Ink4a/Arf−/− males as compared to males from the control Ink4a/Arf−/− group (42.1% vs 8.3%, P = 0.00045) (Table 2).